Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MKLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DUOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDNRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC90B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GLIPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOHH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEX3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF664 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on